ID   RGRF1_RAT               Reviewed;        1244 AA.
AC   P28818;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   02-OCT-2024, entry version 166.
DE   RecName: Full=Ras-specific guanine nucleotide-releasing factor 1;
DE            Short=Ras-GRF1;
DE   AltName: Full=Guanine nucleotide-releasing protein;
DE            Short=GNRP;
DE   AltName: Full=P140 Ras-GRF;
GN   Name=Rasgrf1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=1379346; DOI=10.1038/358351a0;
RA   Shou C., Farusworth C.L., Neel B.G., Feig L.A.;
RT   "Molecular cloning of cDNAs encoding a guanine-nucleotide-releasing factor
RT   for Ras p21.";
RL   Nature 358:351-354(1992).
RN   [2]
RP   FUNCTION, OLIGOMERIZATION, AND INTERACTION WITH RASGRF2.
RX   PubMed=10373510; DOI=10.1128/mcb.19.7.4611;
RA   Anborgh P.H., Qian X., Papageorge A.G., Vass W.C., DeClue J.E., Lowy D.R.;
RT   "Ras-specific exchange factor GRF: oligomerization through its Dbl homology
RT   domain and calcium-dependent activation of Raf.";
RL   Mol. Cell. Biol. 19:4611-4622(1999).
RN   [3]
RP   PHOSPHORYLATION AT SER-71; SER-575; SER-611; SER-760; SER-781 AND SER-854,
RP   UBIQUITINATION, AND MUTAGENESIS OF SER-71 AND SER-575.
RX   PubMed=21382555; DOI=10.1016/j.neuron.2011.02.004;
RA   Lee K.J., Lee Y., Rozeboom A., Lee J.Y., Udagawa N., Hoe H.S., Pak D.T.;
RT   "Requirement for Plk2 in orchestrated ras and rap signaling, homeostatic
RT   structural plasticity, and memory.";
RL   Neuron 69:957-973(2011).
CC   -!- FUNCTION: Promotes the exchange of Ras-bound GDP by GTP.
CC       {ECO:0000269|PubMed:10373510}.
CC   -!- SUBUNIT: Homooligomer and heterooligomer with RASGRF2. Interacts with
CC       USP8, thereby regulating its stability (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The DH (DBL-homology) domain mediates interaction with RASGRF2.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated by PLK2, leading to ubiquitination and degradation
CC       by the proteasome. {ECO:0000269|PubMed:21382555}.
CC   -!- PTM: Ubiquitinated and degraded following phosphorylation by PLK2.
CC       {ECO:0000269|PubMed:21382555}.
CC   -!- PTM: Phosphorylated by SRC and LCK. Phosphorylation by LCK increases
CC       its capacity to stimulate the GDP/GTP exchange on Ras, whereas its
CC       phosphorylation by SRC seems not to have an effect on stimulation
CC       activity (By similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X67241; CAA47666.1; -; mRNA.
DR   PIR; S29083; S29083.
DR   RefSeq; NP_001164002.1; NM_001170531.1.
DR   AlphaFoldDB; P28818; -.
DR   SMR; P28818; -.
DR   BioGRID; 251354; 2.
DR   STRING; 10116.ENSRNOP00000070883; -.
DR   iPTMnet; P28818; -.
DR   PhosphoSitePlus; P28818; -.
DR   PaxDb; 10116-ENSRNOP00000018794; -.
DR   GeneID; 192213; -.
DR   KEGG; rno:192213; -.
DR   UCSC; RGD:620395; rat.
DR   AGR; RGD:620395; -.
DR   CTD; 5923; -.
DR   RGD; 620395; Rasgrf1.
DR   eggNOG; KOG3417; Eukaryota.
DR   InParanoid; P28818; -.
DR   OrthoDB; 68574at2759; -.
DR   PhylomeDB; P28818; -.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   PRO; PR:P28818; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0097440; C:apical dendrite; IDA:RGD.
DR   GO; GO:0016327; C:apicolateral plasma membrane; IDA:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:HGNC-UCL.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0030426; C:growth cone; ISS:HGNC-UCL.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0035254; F:glutamate receptor binding; ISO:RGD.
DR   GO; GO:0005096; F:GTPase activator activity; TAS:UniProtKB.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; ISO:RGD.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; IPI:RGD.
DR   GO; GO:0031267; F:small GTPase binding; IDA:RGD.
DR   GO; GO:0090630; P:activation of GTPase activity; ISS:HGNC-UCL.
DR   GO; GO:0071236; P:cellular response to antibiotic; IEP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0031175; P:neuron projection development; ISS:HGNC-UCL.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IMP:RGD.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; ISS:HGNC-UCL.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; IDA:UniProtKB.
DR   GO; GO:0099170; P:postsynaptic modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:0007265; P:Ras protein signal transduction; IBA:GO_Central.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:0035020; P:regulation of Rac protein signal transduction; ISS:HGNC-UCL.
DR   GO; GO:0046578; P:regulation of Ras protein signal transduction; ISS:HGNC-UCL.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IDA:UniProtKB.
DR   GO; GO:0001975; P:response to amphetamine; IEP:RGD.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; ISO:RGD.
DR   GO; GO:0044342; P:type B pancreatic cell proliferation; ISO:RGD.
DR   CDD; cd00155; RasGEF; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; Dbl homology (DH) domain; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 2.
DR   Gene3D; 1.10.840.10; Ras guanine-nucleotide exchange factors catalytic domain; 1.
DR   Gene3D; 1.20.870.10; Son of sevenless (SoS) protein Chain: S domain 1; 2.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR008937; Ras-like_GEF.
DR   InterPro; IPR000651; Ras-like_Gua-exchang_fac_N.
DR   InterPro; IPR019804; Ras_G-nucl-exch_fac_CS.
DR   InterPro; IPR023578; Ras_GEF_dom_sf.
DR   InterPro; IPR001895; RASGEF_cat_dom.
DR   InterPro; IPR036964; RASGEF_cat_dom_sf.
DR   PANTHER; PTHR23113; GUANINE NUCLEOTIDE EXCHANGE FACTOR; 1.
DR   PANTHER; PTHR23113:SF193; RAS-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 1; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00617; RasGEF; 1.
DR   Pfam; PF00618; RasGEF_N; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   Pfam; PF22697; SOS1_NGEF_PH; 1.
DR   SMART; SM00233; PH; 2.
DR   SMART; SM00147; RasGEF; 1.
DR   SMART; SM00229; RasGEFN; 2.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; DBL homology domain (DH-domain); 1.
DR   SUPFAM; SSF50729; PH domain-like; 2.
DR   SUPFAM; SSF48366; Ras GEF; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 2.
DR   PROSITE; PS00720; RASGEF; 1.
DR   PROSITE; PS50009; RASGEF_CAT; 1.
DR   PROSITE; PS50212; RASGEF_NTER; 1.
PE   1: Evidence at protein level;
KW   Guanine-nucleotide releasing factor; Phosphoprotein; Reference proteome;
KW   Repeat; Ubl conjugation.
FT   CHAIN           1..1244
FT                   /note="Ras-specific guanine nucleotide-releasing factor 1"
FT                   /id="PRO_0000068882"
FT   DOMAIN          22..129
FT                   /note="PH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          204..229
FT                   /note="IQ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          240..426
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          456..582
FT                   /note="PH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          629..743
FT                   /note="N-terminal Ras-GEF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00135"
FT   DOMAIN          1009..1241
FT                   /note="Ras-GEF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00168"
FT   REGION          707..730
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          800..840
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         71
FT                   /note="Phosphoserine; by PLK2"
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MOD_RES         575
FT                   /note="Phosphoserine; by PLK2"
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MOD_RES         611
FT                   /note="Phosphoserine; by PLK2"
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MOD_RES         739
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P27671"
FT   MOD_RES         760
FT                   /note="Phosphoserine; by PLK2"
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MOD_RES         781
FT                   /note="Phosphoserine; by PLK2"
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MOD_RES         854
FT                   /note="Phosphoserine; by PLK2"
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MUTAGEN         71
FT                   /note="S->A: Abolishes degradation by the proteasome."
FT                   /evidence="ECO:0000269|PubMed:21382555"
FT   MUTAGEN         575
FT                   /note="S->A: Abolishes degradation by the proteasome."
FT                   /evidence="ECO:0000269|PubMed:21382555"
SQ   SEQUENCE   1244 AA;  142667 MW;  4B647879E842AF6B CRC64;
     MQKAIRLNDG HVVSLGLLAQ RDGTRKGYLS KRSSDNPKWQ TKWFALLQNL LFYFESDSSS
     RPSGLYLLEG SICKRMPSPK RGTSSKESDK QHHYFTVNFS NDSQKSLELR TDDSKDCDEW
     VAAIARASYK ILATEHEALM QKYLHLLQVV ETEKTVAKQL RQQLEDGEVE IERLKAEIAN
     LIKDNERIQS NQLVAPEDED SDIKKIKKVQ SFLRGWLCRR KWKNIIQDYI RSPHADSMRK
     RNQVVFSMLE AEAEYVQQLH ILVNNFLRPL RMAASSKKPP ITHDDVSSIF LNSETIMFLH
     QIFYQGLKAR IASWPTLVLA DLFDILLPML NIYQEFVRNH QYSLQILAHC KQNRDFDKLL
     KQYEAKPDCE ERTLETFLTY PMFQIPRYIL TLHELLAHTP HEHVERNSLD YAKSKLEELS
     RVMHDEVSET ENIRKNLAIE RMITEGCEIL LDTSQTFVRQ GSLIQVPMSE KGKINKGRLG
     SLSLKKEGER QCFLFSKHLI ICTRGSGSKL HLTKNGVISL IDCTLLDDPE NMDDDGKGQE
     VDHLDFKIWV EPKDSPPFTV ILVASSRQEK AAWTSDIIQC VDNIRCNGLM MNAFEENSKV
     TVPQMIKSDA SLYCDDVDIR FSKTMNSCKV LQIRYASVER LLERLTDLRF LSIDFLNTFL
     HSYRVFTDAV VVLDKLISIY KKPITAIPAR SLELLFSSSH NTKLLYGDAP KSPRASRKFS
     SPPPLAIGTS SPVRRRKLSL NIPIITGGKA LELASLGCPS DGYTNIHSPI SPFGKTTLDT
     SKLCVASSLT RTPEEIDMTT LEESSGFRKP TSDILKEESD DDQSDVDDTE VSPPTPKSFR
     NRITQEFPLF NYNSGIMMTC RDLMDSNRSP LSATSAFAIA TAGANESPAN KEIYRRMSLA
     NTGYSSDQRN IDKEFVIRRA ATNRVLNVLR HWVTKHSQDF ETDDLLKYKV ICFLEEVMHD
     PDLLPQERKA AANIMRTLTQ EEITENHSML DELLLMTEGV KTEPFENHSA MEIAEQLTLL
     DHLVFKSIPY EEFFGQGWMK ADKNERTPYI MKTTRHFNHI SNLIASEILR NEEVSARAST
     IEKWVAVADI CRCLHNYNAV LEITSSINRS AIFRLKKTWL KVSKQTKSLF DKLQKLVSSD
     GRFKNLRETL RNCDPPCVPY LGMYLTDLAF LEEGTPNYTE DGLVNFSKMR MISHIIREIR
     QFQQTTYKIE PQPKVTQYLV DETFVLDDES LYEASLRIEP KLPT
//
